Dapagliflozin Improves Left Ventricular Myocardial Longitudinal Function in Patients With Type 2 Diabetes
Abstract
Subclinical left ventricular (LV) dysfunction is highly prevalent in people with type 2 diabetes mellitus (T2DM) and is independently associated with poor cardiovascular outcome ([1][1]). Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have been shown to reduce hospitalizations for heart...
Paper Details
Title
Dapagliflozin Improves Left Ventricular Myocardial Longitudinal Function in Patients With Type 2 Diabetes
Published Date
Feb 1, 2021
Journal
Volume
14
Issue
2
Pages
503 - 504
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History